However, treatment with anti-EGFR (20.10±0.81%), anti-EGFR-GN (27.81±1.75%), a combination of anti-EGFR and NIR-PTT (26.46±1.16%) and a combination of anti-EGFR-GN and NIR-PTT (41.51±0.54%) induced significant apoptotic cell death (P<0.001). Here, EGFR is linked to ganglioneuroma.